Dr. Hanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-880-7812
Summary
- I am a board certified general nephrologist and internist engaged in academic research and practice.
Education & Training
- Olive View/UCLA Medical CenterFellowship, Nephrology, 2010 - 2012
- Olive View/UCLA Medical CenterResidency, Internal Medicine, 2007 - 2010
- University of California San Diego School of MedicineClass of 2007
- University of California Los Angeles (UCLA)BS, Microbiology Immunology and Molecular Genetics (MIMG), Summa Cum Laude, 1999 - 2003
Certifications & Licensure
- CA State Medical License 2009 - 2026
- American Board of Internal Medicine Nephrology
- ICHICH Good Clinical Practice for Clinical Trial Sites
- UCLABiomedical Research Practices/HIPPA Certification
Awards, Honors, & Recognition
- FACP ACP, 2017
- FASN ASN, 2017
- Phi-Beta-Kappa UCLA, 2003
- Join now to see all
Clinical Trials
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia Start of enrollment: 2009 Jun 01
- Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis Start of enrollment: 2013 Aug 01
- Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2) Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAssociations of interdialytic weight gain in the long intervals with mortality and residual kidney function decline.Yoshikazu Miyasato, Ramy M Hanna, Tsuyoshi Miyagi, Yoko Narasaki, Hiroshi Kimura
Hemodialysis International. International Symposium on Home Hemodialysis. 2023-07-01 - 23 citationsAdvances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review.Niloofar Nobakht, Ramy M Hanna, Maha Al-Baghdadi, Khalid Mohammed Ameen, Farid Arman
Kidney Medicine. 2020-03-01 - 134 citationsA Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease.Ramy M Hanna, Lena Ghobry, Olivia Wassef, Connie M. Rhee, Kamyar Kalantar-Zadeh
Blood Purification. 2020-01-01
Journal Articles
- Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Withou...Francisco Durazo, Ramy M Hanna, Beshoy Yanny, Digestive Diseases and Sciences
- Patient with impaired glucose tolerance and hypertension shown to have moderately advanced diabetic nephropathy on renal biopsyRamy M. Hanna, Proceedings of UCLA Health
- Reverse pseudohyperkalemia complicating management in a patient with chronic kidney diseaseRamy m Hanna MD Rumi Cader MD, Proceedings of Ucla Health
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- 3 patients with injection of intravitreal Vascular Endothelial Growth Factor (VEGF) inhibitors and subsequent exacerbation of chronic proteinuria and hypertension: Int...Hanna RM, Lopez E, Hasnain H, Selamet U, Wilson J, Ekladious Y, Bunnapradist S, Gorin, NKF Research Day, 1/1/2018
- 3 patients with injection of intravitreal Vascular Endothelial Growth Factor (VEGF) inhibitors and subsequent exacerbation of chronic proteinuria and hypertension: Int...Hanna RM, Lopez E, Hasnain H, Selamet U, Wilson J, Ekladious Y, Bunnapradist S, Gorin, UCLA DOM Research Day/NKF Research Day, 1/1/2018
- Secondary membranous nephropathy associated with Anti MUSK related myasthenia gravisHanna RM, Kaldas M, NKF, 1/1/2018
- Join now to see all
Lectures
- Diabetes and your kidneys-a patient education seminarRancho Palos Verdes YMCA - 2/21/2018
- Guest panelist regarding atypical HUS diagnosis.Alexion Pharmaceuticals
- VEGF nephrotoxicityUCLA RRMC
- Join now to see all
Other
- Complement disorders and the kidneys- a patient education toolRamy M. Hanna, UCLA CCORE KIDNEY
- Diabetes and your kidneys-a patient education seminarRamy M. Hanna, UCLA CORE KIDNEY WEBSITE
- Glomerulonephritis-inflammation in the kidneys - a patient education toolRamy M. Hanna, UCLA CORE KIDNEY WEBSITE
https://www.uclahealth.org/core-kidney/workfiles/GN%20pt%20education%20tool%20%285%29.pdf - Join now to see all
Committees
- Conducted fellow-candidate Interviews, UCLA Nephrology 2017 - Present
- Patient Safety Comittee member, Long Beach Memorial 2016 - Present
- UCLA-Health Clinical Research Consortium, UCLA Nephrology
Research History
- Journal Peer Reviewer and EditorSJKDT,International Journal of STD and AIDS, BJMMR, HIV and palliative care, Permanente Journal, AJMH, Journal of advances in medicine, JSSR, Reviewer and Editor ‘South Asian Journal of Research in Nephrology’2012 - Present
- Clinical ResearchOngoing efforts in clinical research ,description of novel pathology, and clinical trials as above2010 - Present
- PIIntravitreal VEGF inhibitor effects on HTN and proteinuria in Diabetics with CKD IRB#17-001284
- Co-PIAcute kidney injury after off label mitra-clip device tricupsid valve repair IRB#17-001845
- Co-PISodium correction with very low dose tolvaptan IRB# 17-001783
Professional Memberships
- Fellow
- Fellow
- National Kidney FoundationMember
Other Languages
- Arabic, Spanish
Industry Relationships
- Speaker, AlexionSpeaker for SolirisDisclosure: Part of 2018 Speaker's Bureau
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: